NeuroSense Therapeutics Ltd. Share Price
NASDAQ: NRSN$2.17
+$2.17 (--%) Last updated on 30 Oct, 2026 | 00:37 ISTNeuroSense Therapeutics Ltd. Stock Performance
NeuroSense Therapeutics Ltd. Share Price Chart
$2.15$2.17
L
H
NeuroSense Therapeutics Ltd. Annual Profit & Loss
All figures in USD
About NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
NeuroSense Therapeutics Ltd. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $4.20 | $2.17 | -54.22% |
Sep 2026 | $0.42 | $4.74 | +1,254.29% |
Aug 2026 | $0.40 | $0.35 | -25.21% |
Jul 2026 | $0.72 | $0.47 | -34.82% |
Jun 2026 | $0.82 | $0.72 | -13.49% |
May 2026 | $0.87 | $0.83 | +0.85% |
Apr 2026 | $0.76 | $0.82 | +9.73% |
Mar 2026 | $0.89 | $0.75 | -17.85% |
Feb 2026 | $0.94 | $0.91 | +1.56% |
Jan 2026 | $0.78 | $0.90 | +32.01% |
Dec 2025 | $1.22 | $0.68 | -42.77% |
Nov 2025 | $1.11 | $1.19 | +11.21% |